search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
infection control & hospital epidemiology july 2018, vol. 39, no. 7 original article


Real-Time, Automated Detection of Ventilator-Associated Events: Avoiding Missed Detections, Misclassifications, and False Detections Due to Human Error


Erica S. Shenoy, MD, PhD;1,2,3,5,6 Eric S. Rosenthal, MD;3,4,5,6 Yu-Ping Shao, MS;4,5 Siddharth Biswal, MS;7 Manohar Ghanta, MS;4,5 Erin E. Ryan, MPH, CCRP;1 Dolores Suslak, MSN, CIC;1 Nancy Swanson, RN, CIC;1 Valdery Moura Junior, MS, MBA;4,5 David C. Hooper, MD;1,2,3,a M. Brandon Westover, MD, PhD3,4,5,6,a


objective. To validate a system to detect ventilator associated events (VAEs) autonomously and in real time.


design. Retrospective review of ventilated patients using a secure informatics platform to identify VAEs (ie, automated surveillance) compared to surveillance by infection control (IC) staff (ie, manual surveillance), including development and validation cohorts.


setting. The Massachusetts General Hospital, a tertiary-care academic health center, during January–March 2015 (development cohort) and January–March 2016 (validation cohort). patients. Ventilated patients in 4 intensive care units.


methods. The automated process included (1) analysis of physiologic data to detect increases in positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2); (2) querying the electronic health record (EHR) for leukopenia or leukocytosis and antibiotic initiation data; and (3) retrieval and interpretation of microbiology reports. The cohorts were evaluated as follows: (1) manual surveillance by IC staff with independent chart review; (2) automated surveillance detection of ventilator-associated condition (VAC), infection-related ventilator-associated complication (IVAC), and possible VAP (PVAP); (3) senior IC staff adjudicated manual surveillance–automated surveillance discordance. Outcomes included sensitivity, specificity, positive predictive value (PPV), and manual surveillance detection errors. Errors detected during the development cohort resulted in algorithm updates applied to the validation cohort.


results. In the development cohort, there were 1,325 admissions, 479 ventilated patients, 2,539 ventilator days, and 47 VAEs. In the validation cohort, there were 1,234 admissions, 431 ventilated patients, 2,604 ventilator days, and 56 VAEs. With manual surveillance, in the development cohort, sensitivity was 40%, specificity was 98%, and PPV was 70%. In the validation cohort, sensitivity was 71%, specificity was 98%, and PPV was 87%. With automated surveillance, in the development cohort, sensitivity was 100%, specificity was 100%, and PPV was 100%. In the validation cohort, sensitivity was 85%, specificity was 99%, and PPV was 100%. Manual surveillance detection errors included missed detections, misclassifications, and false detections.


conclusions. Manual surveillance is vulnerable to human error. Automated surveillance is more accurate and more efficient for VAE surveillance.


Infect Control Hosp Epidemiol 2018;39:826–833


In 2013, the Centers for Disease Control and Prevention (CDC) National Health Safety Network (NHSN), imple- mented the ventilator-associated event (VAE) surveillance algorithm definition.1 The VAE definition replaced prior sur- veillance for ventilator-associated pneumonia (VAP), with 3 tiers of conditions: ventilator-associated condition (VAC), infection-related ventilator-associated complication (IVAC),


and possible VAP (PVAP). The definition was designed to rely on objective and potentially automatable criteria; its features were expected to improve reliability and efficiency of surveil- lance by utilizing data extractable from the electronic health record (EHR).2,3 Since that time, approaches to VAE surveillance using extracts from EHRs have been described,4–7 with varying levels


Affiliations: 1. Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts; 2. Division of Infectious Diseases, Massachusetts General


Hospital, Boston, Massachusetts; 3. Harvard Medical School, Boston, Massachusetts; 4. Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; 5. Clinical Data Animation Center, Massachusetts General Hospital, Boston, Massachusetts; 6. Health Sciences and Technology Program, Harvard Medical School, Boston, Massachusetts; 7. Department of Computer Science, Georgia Institute of Technology College of Computing, Atlanta, Georgia.


PREVIOUS PRESENTATION. This work was presented at ID Week 2017 (abstract no. 2151) on October 7, 2017, in San Diego, California. aSenior authors with equal contribution.


© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 0899-823X/2018/3907-0009. DOI: 10.1017/ice.2018.97 Received December 4, 2017; accepted April 5, 2018; electronically published May 17, 2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144